Monoclonal antibodies in cancer immunotherapy


KİMİZ-GEBOLOGLU I., GULCE-IZ S. , Biray-Avci C.

MOLECULAR BIOLOGY REPORTS, cilt.45, ss.2935-2940, 2018 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 45 Konu: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s11033-018-4427-x
  • Dergi Adı: MOLECULAR BIOLOGY REPORTS
  • Sayfa Sayısı: ss.2935-2940

Özet

Nowadays, in cancer treatments, immunotherapy which can be classified as a cancer type specific therapy is more popular than non-specific therapy methods such as surgery, radiotherapy and chemotherapy. The main aim of immunotherapy is to enable patients' immune system to target cancer cells and destroy them. The mainly used treatment methods in cancer immunotherapy are cancer vaccines, adoptive cell therapy, cytokines and monoclonal antibodies. In this review, we discuss the immunotherapy approaches, especially monoclonal antibodies which are mostly used in cancer immunotherapy in clinical applications.